You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment in 2006 [see all tables in this series...]

Part (iii) Secondary drugs among outpatient and inpatient clients entering treatment for primary amphetamines and ecstasy use (number of citations)

Secondary drug	Amphetamines		MDMA and other derivatives
Secondary drug	Outpatient	Inpatient	Outpatient	Inpatient
Opioids	423	202	66	4
Cocaine	492	60	363	16
Cannabis	2249	1116	507	88
Alcohol	1185	416	349	20
Stimulants (other than cocaine)	506	94	249	1
Hypnotics and sedatives	219	35	48	1
Hallucinogens	104	60	95	0
Volatile	52	29	31	6
Other substances	125	51	23	3
Total number of citations	5355	2063	1731	139

Notes:

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2007 — Table TDI by centre type.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)